Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 5
1993 2
1994 1
1995 1
1996 2
1997 2
1998 2
2000 2
2001 1
2002 2
2003 1
2004 4
2005 5
2006 1
2007 5
2008 2
2009 2
2010 5
2011 5
2012 12
2013 6
2014 7
2015 8
2016 9
2017 5
2018 4
2019 10
2020 6
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group. Ramos-Casals M, et al. Among authors: kruize aa. Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31. Ann Rheum Dis. 2020. PMID: 31672775
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C. Seror R, et al. Among authors: kruize aa. RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. RMD Open. 2015. PMID: 26509054 Free PMC article. Review.
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.
Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force. Seror R, et al. Among authors: kruize aa. Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22. Ann Rheum Dis. 2011. PMID: 21345815
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.
Brito-Zerón P, Retamozo S, Kostov B, Baldini C, Bootsma H, De Vita S, Dörner T, Gottenberg JE, Kruize AA, Mandl T, Ng WF, Seror R, Tzioufas AG, Vitali C, Bowman S, Mariette X, Ramos-Casals M. Brito-Zerón P, et al. Among authors: kruize aa. RMD Open. 2019 Oct 28;5(2):e001064. doi: 10.1136/rmdopen-2019-001064. eCollection 2019. RMD Open. 2019. PMID: 31749986 Free PMC article. Review.
Optimizing conventional DMARD therapy for Sjögren's syndrome.
van der Heijden EHM, Kruize AA, Radstake TRDJ, van Roon JAG. van der Heijden EHM, et al. Among authors: kruize aa. Autoimmun Rev. 2018 May;17(5):480-492. doi: 10.1016/j.autrev.2018.03.003. Epub 2018 Mar 9. Autoimmun Rev. 2018. PMID: 29526636 Free article. Review. No abstract available.
Procedures related to connective tissue disease.
Kruize AA, Bijlsma JW. Kruize AA, et al. Best Pract Res Clin Rheumatol. 2005 Jun;19(3):417-36. doi: 10.1016/j.berh.2005.01.008. Best Pract Res Clin Rheumatol. 2005. PMID: 15939367 Review.
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
Hamkour S, van der Heijden EH, Lopes AP, Blokland SLM, Bekker CPJ, Van Helden-Meeuwsen CG, Versnel MA, Kruize AA, Radstake TR, Leavis HL, Hillen MR, van Roon JA. Hamkour S, et al. Among authors: kruize aa. RMD Open. 2023 Aug;9(3):e002979. doi: 10.1136/rmdopen-2023-002979. RMD Open. 2023. PMID: 37532471 Free PMC article.
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.
Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, Kruize AA, Tzioufas A, Vitali C, Buyon J, Izmirly P, Fox R, Ramos-Casals M; Eular Sjögren Syndrome Task Force. Brito-Zerón P, et al. Among authors: kruize aa. Expert Rev Clin Immunol. 2016;12(2):137-56. doi: 10.1586/1744666X.2016.1109449. Epub 2015 Dec 22. Expert Rev Clin Immunol. 2016. PMID: 26691952 Review.
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's Syndrome.
Retamozo S, Baldini C, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernández-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vissink A, Vitali C, Bowman SJ, Mariette X, Ramos-Casals M, Brito-Zerón P. Retamozo S, et al. Among authors: kruize aa. Drugs Aging. 2021 Apr;38(4):265-284. doi: 10.1007/s40266-021-00838-6. Epub 2021 Feb 23. Drugs Aging. 2021. PMID: 33619703 Review.
110 results